COP vs PRCT · P/E 19, rev $58.94B vs rev $224.5M
ConocoPhillips (COP) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
COP currently screens at market cap $135.49B and trailing P/E 18.8. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the COP and PRCT stock pages for the full models.
Not investment advice.